Directory
>
Priya Chaturvedi
Priya Chaturvedi
Vice President, Head of Global Clinical Quality (GCQA, GCQM and Global Process & Standards) | Eisai US
Upper Merion Township, Pennsylvania, United States
Priya Chaturvedi
Summary
Priya Chaturvedi is a seasoned professional with over 25 years of experience in the pharmaceutical industry, specializing in clinical quality assurance and operational excellence. Currently serving as the Vice President and Head of Global Clinical Quality at Eisai, she has a strong background in regulatory affairs and quality management, overseeing significant drug approvals including Lenvima and Lecanemab. Priya's expertise spans various facets of clinical development, with a particular focus on the Asia Pacific region, including China. She holds a PhD in Oncology and Cancer Biology from Temple University School of Medicine, reflecting her deep commitment to advancing medical science. Known for her strong leadership abilities, she has successfully managed large teams and complex projects across major pharmaceutical companies like Merck and Pfizer. Priya is passionate about fostering innovation in drug development and enhancing clinical operations to improve patient outcomes.
Priya Chaturvedi
Work Experience
Vice President, Head of Global Clinical Quality (GCQA, GCQM and Global Process & Standards) at
Eisai
September 2021 - Present
Vice President Global Clinical Quality Assurance at
Eisai US
September 2019 - Present
Executive Director, Clinical Quality Assurance at
Merck
June 2016 - August 2019
Medical and Clinical Affairs- BU Quality and Oversight Lead at
Pfizer, Inc.
February 2015 - June 2016
Director, Compliance and Oversight at
PFIZER PHARMACEUTICALS (HONGKONG) LIMITED
February 2012 - February 2015
TA Head of US Clinical Operations -Vaccines at
Pfizer, Inc.
December 2010 - February 2012
Vaccine Clinical Program Management at
GSK
January 2008 - January 2010
BioPharm Clin Program Management at
GSK
January 2007 - January 2008
Manager, Global Porfolio and Project management at
GSK
January 2005 - January 2007
Project Leader, Early drug development at
Glaxosmithkline
January 1999 - January 2005
Priya Chaturvedi
Education
Temple University School of Medicine, Doctor Of Philosophy (Phd)
January 1995 - January 1998
Temple Med School, Phd.
January 1994 - January 1998
Frequently Asked Questions about Priya Chaturvedi
What is Priya Chaturvedi email address?
Priya Chaturvedi's primary email address is ****************@merck.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Priya Chaturvedi work for?
Priya Chaturvedi is a Vice President, Head of Global Clinical Quality (GCQA, GCQM and Global Process & Standards) at Eisai US, a company specializing in Biological products, except diagnostic.
Where Priya Chaturvedi graduated from?
Priya Chaturvedi holds a degree in Oncology And Cancer Biology from Temple University School of Medicine.
How can I directly contact Priya Chaturvedi?
To contact Priya Chaturvedi directly, you can use the email address ****************@merck.com. Complete contact information is available upon registration with Muraena.
Who is Priya Chaturvedi?
Priya Chaturvedi is a seasoned professional with over 25 years of experience in the pharmaceutical industry, specializing in clinical quality assurance and operational excellence. Currently serving as the Vice President and Head of Global Clinical Quality at Eisai, she has a strong background in regulatory affairs and quality management, overseeing significant drug approvals including Lenvima and Lecanemab. Priya's expertise spans various facets of clinical development, with a particular focus on the Asia Pacific region, including China. She holds a PhD in Oncology and Cancer Biology from Temple University School of Medicine, reflecting her deep commitment to advancing medical science. Known for her strong leadership abilities, she has successfully managed large teams and complex projects across major pharmaceutical companies like Merck and Pfizer. Priya is passionate about fostering innovation in drug development and enhancing clinical operations to improve patient outcomes.
Priya`s contact details
****************@merck.com
****************@eisai.com
Colleagues
Executive Director
President, Partnership Management Core Functional Unit
Executive Vice President, Purpose & Chief Business Officer
Chief Administrative Officer & Executive Vice President - Integrity
Deputy President & Head Of Precision Chemistry – G2D2
Executive Director. International Product Safety
Executive Director, US Payer Markets (Neurology and Oncology)
Executive Director, Statistical Programming, DHBL-CEG
Chief Medical Officer, Senior Vice President, Head of Global Medical Affairs, Neurology
Executive Director, External Stakeholder Engagement, Ad, Global Medical Affairs, Nbg At Eisai Us